Neoplasia Flashcards
nitrosamines = carcinogen assoc with
gastric cancer
polycyclic aromatic hydrocarbons = carcinogen assoc with
bronchogenic carcinoma
asbestos = carcinogen assoc with
- bronchogenic carcinoma, mesothelioma
chromium and nickel = carcinogen assoc with
bronchogenic carcinoma
arsenic = carcinogen assoc with
- squamous cell carcinomas of skin and lung
- angiosarcoma of liver
vinyl chloride = carcinogen assoc with
angiosarcoma of liver
aromatic amines and as dyes = carcinogen assoc with
hepatocellular carcinoma
alkylating agents = carcinogen assoc with
leukemia, lymphoma, etc
benzene = carcinogen assoc with
AML
naphthylamine = carcinogen assoc with
bladder cancer (transitional cell)
how do we screen for potential carcinogens
Ames test
Hep B virus is associated with
hepatocellular carcinoma
EBV is associated with
- burkitt lymphoma
- B cell lymphomas in immunosuppressed patients
- nasopharyngeal carcinoma (China)
HPV is associated with
- benign squamous papillomas (warts - condyloma acuminatum)
- a variety of carcinomas (cervical, vulvar, vaginal, penile, anal
Ultraviolet B sunlight carcinogenesis
- produces pyrimidine dimers in DNA –> transcriptional errors and mutations of oncogenes and TSG –> increases risk of skin cancer
xeroderma pigmentosum
- AR
- defect in DNA repair
- pyrimidine dimers formed with UVB can’t be repaired –> skin cancer
when are cells most sensitive to radiation
during mitosis or G2
protooncogenes
- normal cellular genes involved with growth and cellular differentiation
- when protooncogenes get mutated–> oncogenes
- oncogenes are derived from protooncogenes, either by a change in gene sequence –> new product (oncoprotein) or a loss of gene regulation resulting in overexertion of a normal gene product
- oncogenes only need one hit to express symptoms (vs TSG need 2 hits)
hst-1 and int-2
- tumor
- gene product
- MOA
- oncogenes
- tumor: cancer of stomach, breast, bladder, melanoma
- gene product: growth factors: fibroblast growth factor
- MOA: overexpression
sis
- tumor
- gene product
- MOA
- oncogene
- tumor: astrocytoma
- gene product: platelet derived growth factor
- MOA: overexpression
erb-B1
- tumor
- gene product
- MOA
- oncogene
- tumor: squamous cell carcinoma (SCC) of lung
- gene product: growth factor receptors: epidermal growth factor receptor
- MOA: overexpression
erb-B2
- normal function
- tumor
- gene product
- MOA
- oncogene
- receptor synthesis
- tumor: breast, ovary, lung
- gene product: epidermal growth factor receptor
- MOA: Amplification (have more than 2 copies)
erb-B3
- tumor
- gene product
- MOA
- oncogene
- tumor: breast
- gene product: epidermal growth factor receptor
- MOA: overexpression
ret
- tumor
- gene product
- MOA
- oncogene; tyrosine kinase
- tumor: MEN II and III, familial thyroid (medullary) cancer
- gene product: glial neurotrophic factor receptor (S100+)
- MOA: point mutation
abl
- tumor
- gene product
- MOA
- oncogene, tyrosine kinase activity; Chromosome 22 = philadelphia gene
- tumor: CML, ALL (5%)
- gene product: signal transduction proteins: bcr-abl fusion protein with tyrosine kinase activity (–> always on)
- aka p210kD fusion protein
- MOA: translocation t(9;22)
- tyrosine kinase are signal transduction proteins –> fusion protein causes cells to grow/proliferate
- DOC: imatinib –> blocks ATP binding site on tyrosine kinase
ki-ras
- normal function
- tumor
- gene product
- MOA
- MC oncogene to be overexpressed
- GTP signal transduction (gene product = GTPase)
- tumor: lung, pancreas, colon; neurofibromas
- gene product: GTP binding protein (signal transduction)
- MOA: point mutation
c-myc
- tumor
- gene product
- MOA
- oncogene on Ch 8; normally fx = nuclear transcription factor
- tumor: burkitt lymphoma (kids)
- gene product: nuclear regulatory protein
- MOA: translocation t(8;14) –> overexpression
- promotes cellular proliferation:
- when associated with p53, leads to apoptosis and
- when associated with bcl-2 inhibits apoptosis
L-myc
- tumor
- gene product
- MOA
- oncogene on Ch 1
- tumor: small cell lung carcinoma
- gene product: nuclear regulatory protein (transcription factor)
- MOA: amplification
N-myc
- tumor
- gene product
- MOA
- oncogene
- tumor: neuroblastoma (if <18mo = better prognosis; if >18mo worse prognosis, spread)
- gene product: nuclear regulatory protein (transcription factor)
- MOA: amplification (2 = normal, the more copies you have the worse the prognosis)
bcl-1
- tumor
- gene product
- MOA
- oncogene
- tumor: mantle cell lymphoma
- gene product: cell cycle regulatory proteins: cyclin D protein
- MOA: translocation t(11;14)
CDK4
- tumor
- gene product
- MOA
- oncogene
- tumor: melanoma, glioblastomamultiforma (GBM)
- gene product: cyclin dependent kinase
- MOA: amplification
bcl-2
- function
- tumor
- gene product
- MOA
- oncogene: overexpression –> fountain of youth
- if doesn’t die, accumulates mutations until eventually develops cancer
- tumor: follicular non hodgkins lymphoma (arises from B lymphocytes in LN)
- MOA: translocation t(14;18) causes overexpression of Bcl-2 protein product–> prevents apoptosis of B lymphocytes (never die) –> follicular lymphoma = MC malignant lymphoma affecting adults in US
- tumor genesis related to changes in regulation of apoptosis: normally bcl-2 prevents apoptosis, but here the bcl-2 regulator of apoptosis is overexpressed bc the translocation connects the immunoglobulin heavy chain gene on Ch14 (which turns on easily in B lymphocytes) to the bcl-2 gene on Ch 18
- -> this leads to a situation where lymphocytes fail to die as expected and instead produce a tumor
tumor suppressor genes
- encode proteins that regulate and suppress cell proliferation by inhibiting progression of the cell through the cell cycle
- need 2 hits to express symptoms aka to knock out the TSG (vs oncogenes only need one hit)
- 1st hit could be gremlin, 2nd hit = acquired
- MOA of TSG varies. Ex)
- p53 prevents a cell with damaged DNA from entering S-phase.
- Rb prevents the cell from entering S-phase until the appropriate growth signals are present
VHL
- function
- chromosome
- tumor
- TSG, normal protein product inhibits hypoxia inducible factor 1a
- chromosome: 3p25
- function: regulates nuclear transcription
- tumor: von hippel-lindau disease (bilateral renal cell carcinoma, pheochromocytoma, hemangioblastomas), renal cell carcinoma
WT-1
- function
- chromosome
- tumor
- TSG, regulates nuclear transcription
- chromosome: 11p13
- tumor: wilms tumor
- WT-1 is by PAX-6 so they’re knocked out together–> WAGR syndrome: kid has aniridia look for films tumor
WT-2
- function
- chromosome
- tumor
- TSG, regulates nuclear transcription
- chromosome: 11p15
- tumor: wilms tumor
Rb
- chromosome
- function
- tumor
- TSG
- chromosome: 13q14 (13 looks like B)
- function: Inhibits E2F; blocks G1 to S phase of cell cycle
- tumor: retinoblastoma, osteosarcoma (sunburst, codmans triangle)
- MOA: “policeman of checkpoints”
- if have familial Rb have 40% chance of other tumor developing
- if familial type of RB: develops early, both eyes. born with 1 germline mutation and acquire point mutation.
- if sporadic (non-familial) type: both alleles inactivated in somatic mutation in one of the retinoblasts –> occurs later in life; unilateral.
- assoc with retinoblastoma, osteogenic sarcoma, breast cancer
p53
- function
- chromosome
- tumor
- TSG (TP53), MC knocked out in most cancers!!
- p53 activates p21, inhibits G1 to S phase, repairs DNA, activates BAX
- chromosome: 17p13.1
- tumor: Li fraumeni (Li looks like an upside down 17)
- lung, breast, colon, etc
- p53 tells Rb to stop cell and if no it lets cytochrome c out of mitochondria –> apoptosis
- p53 is often knocked out in malignant tumors
- p53 promotes apoptosis in mutated cells by stimulating bax synthesis.
BRCA-1
- chromosome
- function
- tumor
- TSG
- chromosome: 17q12-21
- function: regulates DNA repair
- tumor: hereditary breast, ovarian, pancreatic, colon and prostate cancers
- “there are 17 letters in angelina jolie-pitt”
BRCA-2
- chromosome
- function
- tumor
- TSG
- chromosome: 13q12-13
- function: regulates DNA repair
- tumor: hereditary breast cancer
APC
- chromosome
- function
- tumor
- TSG
- chromosome: 5q21 (5 letters in colon)
- function: prevents nuclear transcription
- negative regulator of β-catenin/WNT pathway
- tumor: Adenomatous Polyps and Colon cancer; FAP
DCC
- chromosome
- tumor
- TSG
- chromosome: 18q21
- tumor: colon cancer
NF-1
- chromosome
- tumor
- TSG; turns off ras
- chromosome: 17q11.2
- gene product: neurofibromin (Ras GTPase activating protein)
- tumor: neurofibromas, cafe au last spots, lisch nodules
NF-2
- chromosome
- tumor
- TSG
- chromosome: 22q12
- gene product: merlin (Schwannomin protein)
- tumor: schwannomas of acoustic nerve = acoustic neuromas, meningiomas
keratin
- normal tissue
- tumors
- intermediate filament
- normal tissue: all epithelial cells
- tumors: carcinomas
vimentin
- normal tissue
- tumors
- intermediate filament
- normal tissue: mesenchymal cells
- tumors: sarcomas
desmin
- normal tissue
- tumors
- intermediate filament
- normal tissue: muscle cells; actin also found in muscle
- tumors: uterine leiomyoma, rhabdomyosarcoma
neurofilament
- normal tissue
- tumors
- intermediate filament
- normal tissue: CNS and PNS neurons, neural crest derivatives
- tumors: pheochromocytoma, neuroblastoma
glial fibrillary acidic protein (GFAP)
- normal tissue
- tumors
- intermediate filament
- normal tissue: glial cells (i.e. astrocytes, oligodendrocytes, ependymal cells)
- tumors: astrocytomas, ependymomas
increased AFP in pregnant woman
neural tube defects